Document is current
Any future updates will be listed below
-
Authors
Wenthe, Jessica https://orcid.org/0000-0003-4385-7568
Naseri, Sedigheh
Hellström, Ann-Charlotte
Wiklund, Helena Jernberg
Eriksson, Emma
Loskog, Angelica https://orcid.org/0000-0001-8583-6138
-
Funding
Funding for this research was provided by:
Cancerfonden
Vetenskapsrådet
- License Information
-
More Information
Article History
Received: 2 March 2020
Revised: 2 April 2020
Accepted: 15 April 2020
First Online: 1 May 2020
Compliance with ethical standards
:
: Dr. Loskog discloses conflicts of interest connected to the data presented in this paper. Dr. Loskog is the CEO and board member of Lokon Pharma AB and holds a royalty agreement and a contract research agreement with Lokon Pharma AB at her adjunct position at Uppsala University. The other authors have no conflicts of interest to disclose.
